Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $1.01, versus $0.00 reported last year. Revenue for the quarter came in at $675.3 million versus the consensus estimate of $665.84 million.

"We continue to empower our sales leaders to effectively acquire customers through enabling social sharing, providing innovative products like ageLOC LumiSpa, and implementing our enhanced sales compensation program, Velocity. We are on pace to generate a very strong finish to this year which we believe sets us up well for 2019," Wood concluded.

"We generated 20 percent year-over-year revenue growth and 24 percent improvement in earnings in the quarter," said Mark Lawrence, chief financial officer. "For the year, we are increasing our annual revenue guidance to $2.66 billion to $2.68 billion with earnings per share of $3.48 to $3.55. This earnings guidance reflects the $0.20 foreign currency translation loss from the second and third quarters and the $0.16 purchase accounting charge. We are projecting fourth-quarter revenue of $665 to $685 million, including a 4 to 5 percent negative currency impact, and earnings per share of $1.00 to $1.07, or $1.04 to $1.11 when excluding the estimated $0.04 purchase accounting charge. As a reminder, in the fourth quarter of 2017, we held an ageLOC LumiSpa global introduction which generated $130 million in sales," concluded Lawrence.

GUIDANCE:

Nu Skin Enterprises sees FY2018 EPS of $3.48-$3.55, versus the consensus of $3.61. Nu Skin Enterprises sees FY2018 revenue of $2.66-2.68 billion, versus the consensus of $2.66 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.